These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1838035)

  • 1. The identification of type 1 Gaucher disease patients, asymptomatic cases and carriers in The Netherlands using urine samples: an evaluation.
    Aerts JM; Sa Miranda MC; Wanzeller de Lacerda L; van Weely S; Donker-Koopman W; Brouwer-Kelder B; Jansen DC; van Leeuwen M; Schram AW; Tsiapara A
    Clin Chim Acta; 1991 Dec; 203(2-3):349-61. PubMed ID: 1838035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease.
    Rudensky B; Paz E; Altarescu G; Raveh D; Elstein D; Zimran A
    Blood Cells Mol Dis; 2003; 30(1):97-9. PubMed ID: 12667991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease.
    Aerts JM; Donker-Koopman WE; Koot M; Barranger JA; Tager JM; Schram AW
    Clin Chim Acta; 1986 Jul; 158(2):155-63. PubMed ID: 2943536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
    Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
    Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Gaucher disease carriers: glucocerebrosidase antigen and DNA analysis.
    Lacerda L; Amaral O; Pinto R; Aerts J; Sá Miranda MC
    Biochem Med Metab Biol; 1993 Oct; 50(2):190-6. PubMed ID: 8260196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.
    Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J
    Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
    van Weely S; Brandsma M; Strijland A; Tager JM; Aerts JM
    Biochim Biophys Acta; 1993 Mar; 1181(1):55-62. PubMed ID: 8457606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
    Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
    van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM
    J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
    Raghavan SS; Topol J; Kolodny EH
    Am J Hum Genet; 1980 Mar; 32(2):158-73. PubMed ID: 6770675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
    Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
    FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.
    Aerts JM; Sa Miranda MC; Brouwer-Kelder EM; Van Weely S; Barranger JA; Tager JM
    Biochim Biophys Acta; 1990 Oct; 1041(1):55-63. PubMed ID: 2223847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease in patients and obligate carriers of Gaucher disease.
    Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
    Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
    J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
    Choy FY
    Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease: a lysosomal neurodegenerative disorder.
    Huang WJ; Zhang X; Chen WW
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1219-26. PubMed ID: 25912581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
    Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
    Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.
    Van Weely S; Aerts JM; Van Leeuwen MB; Heikoop JC; Donker-Koopman WE; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1990 Aug; 191(3):669-77. PubMed ID: 2143986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease: molecular screening of the glucocerebrosidase 1601G and 1601A alleles in Victoria, British Columbia, Canada.
    Choy FY; Linsey J; MacLeod PD
    J Med Genet; 1997 Jan; 34(1):83-5. PubMed ID: 9032656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.